Epidermal growth factor receptor in tumor angiogenesis
2004; Elsevier BV; Volume: 18; Issue: 5 Linguagem: Inglês
10.1016/j.hoc.2004.06.002
ISSN1558-1977
Autores Tópico(s)Cancer Treatment and Pharmacology
ResumoThis article focuses on the preclinical evidence for activation of the epidermal growth factor receptor (EGFR) in promoting angiogenesis and the efficacy of anti-EGFR agents in inhibiting angiogenesis and tumor growth.
Referência(s)